Cystic fibrosis (CF) is an autosomal recessive disorder generally characterized by chronic obstructive lung disease, pancreatic insufficiency, poor gastrointestinal tract absorption and elevated sweat electrolytes. Other manifestations of CF have now been recognized to include male infertility caused by bilateral absence of the vas deferens, recurrent nasal polyps, rectal prolapse and chronic bronchiectasis. The incidence of CF varies widely among different ethnic and racial groups, (from 1:3300 live births in those of Northern European descent, 1:6400 for Southern European groups, 1:8500 for American Hispanics, 1:17,000 for African-Americans, to being extremely rare in Asian populations).
Recommendations by an independent Consensus Panel convened by the NIH on genetic testing for CF (released on April 16, 1997) are the following:
SAMPLE REQUIREMENTS: |
Blood: 3-5 ml purple top (EDTA) vacutainer of whole blood inverted several times to mix. Forward within 48 hours at room temperature. |
Amniotic Fluid: 10-15 ml amniotic fluid from 14th-17th week of gestation or one confluent T25 flask of cultured cells. Send specimen refrigerated, but not frozen (do not ship on dry ice). Please use an overnight courier service. |
Test Method: Next Generation Sequencing of all coding regions of CFTR gene |
Turn around time: 5-7 days |
Report: will include assay results, background information, and a calculation of residual carrier risk if results are negative |
Residual Risk Comparison | Carrier Risk Before Testing | RUTGERS NJMS CFTR Sequencing Residual Risk | 60 Mutation Residual Risk | 23 Mutation Residual Risk |
Ashkenazi Jewish | 1 in 24 | 1/2301 | 1/455 | 1/380 |
Non-Hispanic Caucasian | 1 in 25 | 1/1201 | 1/312 | 1/200 |
Hispanic White | 1 in 58 | 1/2851 | 1/263 | 1/200 |
African American | 1 in 61 | 1/3001 | 1/270 | 1/170 |
Asian American | 1 in 94 | 1/4651 | 1/208 | 1/180 |
Detection Rates are based on mutation frequencies in patients affected with Cystic Fibrosis. Detection rates may vary in patients with CFTR related conditions. Detection rates for mixed or unknown ethnicity cannot be determined. All interpretation assumes that the individual is clinically unaffected and has no family history of Cystic Fibrosis. |